- Home
- MUX vs BCYC Comparison
MUX vs BCYC Comparison
Compare MUX & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- BCYC
- Stock Information
- Founded
- MUX 1979
- BCYC 2009
- Country
- MUX Canada
- BCYC United Kingdom
- Employees
- MUX N/A
- BCYC N/A
- Industry
- MUX Precious Metals
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- MUX Basic Materials
- BCYC Health Care
- Exchange
- MUX Nasdaq
- BCYC Nasdaq
- Market Cap
- MUX 579.8M
- BCYC 492.1M
- IPO Year
- MUX N/A
- BCYC 2019
- Fundamental
- Price
- MUX $13.50
- BCYC $6.92
- Analyst Decision
- MUX Strong Buy
- BCYC Buy
- Analyst Count
- MUX 2
- BCYC 11
- Target Price
- MUX $16.00
- BCYC $22.91
- AVG Volume (30 Days)
- MUX 1.5M
- BCYC 213.9K
- Earning Date
- MUX 11-04-2025
- BCYC 10-30-2025
- Dividend Yield
- MUX N/A
- BCYC N/A
- EPS Growth
- MUX N/A
- BCYC N/A
- EPS
- MUX N/A
- BCYC N/A
- Revenue
- MUX $168,169,000.00
- BCYC $19,281,000.00
- Revenue This Year
- MUX N/A
- BCYC N/A
- Revenue Next Year
- MUX $7.52
- BCYC N/A
- P/E Ratio
- MUX N/A
- BCYC N/A
- Revenue Growth
- MUX N/A
- BCYC N/A
- 52 Week Low
- MUX $6.38
- BCYC $6.10
- 52 Week High
- MUX $14.29
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- MUX 63.10
- BCYC 41.28
- Support Level
- MUX $13.28
- BCYC $6.77
- Resistance Level
- MUX $14.25
- BCYC $7.32
- Average True Range (ATR)
- MUX 0.66
- BCYC 0.39
- MACD
- MUX 0.03
- BCYC 0.01
- Stochastic Oscillator
- MUX 77.03
- BCYC 19.04
About MUX McEwen Mining Inc.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.